Delivery Order SPE2DB22D3004-SPE2DB26FQ81F
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.59 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 master contract vehicle designed to supply pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $19,920.62 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.74 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,046.31 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $8,586.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $2,828.40. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,015.32 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,847.30 by the Defense Logistics Agency on October 23, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...